Newly identified biomarkers via the Promarker™ platform provide a breakthrough for Proteomics International in the effort to create a world-first test for endometriosis.
Patent application filed for the invention, which uses protein biomarkers taken via a standard blood sample as a novel test for diagnosing endometriosis.